| 1 |
Famurewa AC, Asogwa NT, Ezea SC. Antidiabetic drug sitagliptin blocks cyclophosphamide cerebral neurotoxicity by activating Nrf2 and suppressing redox cycle imbalance, inflammatory iNOS/NO/NF-κB response and caspase-3/Bax activation in rats. Int Immunopharmacol 2023;116:109816. [PMID: 36774854 DOI: 10.1016/j.intimp.2023.109816] [Reference Citation Analysis]
|
| 2 |
Salama MM, Zaghloul RA, Khalil RM, El-shishtawy MM. Sitagliptin Potentiates the Anti-Neoplastic Activity of Doxorubicin in Experimentally-Induced Mammary Adenocarcinoma in Mice: Implication of Oxidative Stress, Inflammation, Angiogenesis, and Apoptosis. Sci Pharm 2022;90:42. [DOI: 10.3390/scipharm90030042] [Reference Citation Analysis]
|
| 3 |
Huang S, Huang Y, Lin W, Wang L, Yang Y, Li P, Xiao L, Chen Y, Chu Q, Yuan X, Tang C. Sitagliptin Alleviates Radiation-Induced Intestinal Injury by Activating NRF2-Antioxidant Axis, Mitigating NLRP3 Inf--lammasome Activation, and Reversing Gut Microbiota Disorder. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/2586305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Yin R, Xu Y, Wang X, Yang L, Zhao D. Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment. Molecules 2022;27:3055. [PMID: 35630534 DOI: 10.3390/molecules27103055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 5 |
Michel HE, Tadros MM, Hendy MS, Mowaka S, Ayoub BM. Omarigliptin attenuates rotenone-induced Parkinson's disease in rats: Possible role of oxidative stress, endoplasmic reticulum stress and immune modulation. Food Chem Toxicol 2022;164:113015. [PMID: 35439590 DOI: 10.1016/j.fct.2022.113015] [Reference Citation Analysis]
|
| 6 |
Krzystek-Korpacka M, Fleszar MG, Fortuna P, Gostomska-Pampuch K, Lewandowski Ł, Piasecki T, Kosyk B, Szeląg A, Trocha M. Modulation of Prostanoids Profile and Counter-Regulation of SDF-1α/CXCR4 and VIP/VPAC2 Expression by Sitagliptin in Non-Diabetic Rat Model of Hepatic Ischemia-Reperfusion Injury. Int J Mol Sci 2021;22:13155. [PMID: 34884960 DOI: 10.3390/ijms222313155] [Reference Citation Analysis]
|
